EDGAR Filing Documents for 0001171843-13-003986

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001171843-13-003986

Filing Date

2013-10-15

Accepted

2013-10-15 10:51:31

Documents

Period of Report

2013-08-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	f6k_101513.htm	6-K	20745
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	673365
3	EXHIBIT 99.2	exh_992.htm	EX-99.2	329567
4	EXHIBIT 99.3	exh_993.htm	EX-99.3	13366
5	EXHIBIT 99.4	exh_994.htm	EX-99.4	13696
6		logo.jpg	GRAPHIC	16516
	Complete submission text file	0001171843-13-003986.txt		1074613

Mailing Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3

Business Address 225 PROMENADE DU CENTROPOLIS, SUITE 200 LAVAL A8 H7T 3B3 (450) 687-2262

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)